© 2016 TransBCR

Images courtesy of Walter and Eliza Hall Institute

                                                           ***Study now closed to recruitment***
Pre-Treat

 

Recruiting at: Royal Melbourne Hospital and Royal Womens Hospital

Primary Investigator: Professor Geoff Lindeman

Clinical trial registerACTRN12614000695606 

 

A window study of short-term pre-operative treatment with tamoxifen or letrozole in women with estrogen receptor (ER) positive breast cancer.

 

Women who are consented for the Breast Biomarker Project with histologically confirmed invasive ductal or lobular carcinoma and estrogen receptor positive disease are likely eligible for enrolment. There must be a clear intention to treat with surgery.